2019
DOI: 10.1007/s00428-019-02726-2
|View full text |Cite
|
Sign up to set email alerts
|

Molecular findings in maxillofacial bone tumours and its diagnostic value

Abstract: According to the WHO, mesenchymal tumours of the maxillofacial bones are subdivided in benign and malignant maxillofacial bone and cartilage tumours, fibro-osseous and osteochondromatous lesions as well as giant cell lesions and bone cysts. The histology always needs to be evaluated considering also the clinical and radiological context which remains an important cornerstone in the classification of these lesions. Nevertheless, the diagnosis of maxillofacial bone tumours is often challenging for radiologists a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
18
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 49 publications
(58 reference statements)
0
18
0
1
Order By: Relevance
“…These tumours represent 0.1% of all tumours of the head and neck region and may occur in the nasal cavity, maxilla, and mandible in addition to the larynx. In regard to the larynx, ChS accounts for 1% of all laryngeal neoplasms[ 2 , 3 ]. Although these tumours rarely occur in the larynx, they have the second highest frequency after tumours originating from epithelial tissue, squamous cell carcinoma and adenocarcinoma[ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…These tumours represent 0.1% of all tumours of the head and neck region and may occur in the nasal cavity, maxilla, and mandible in addition to the larynx. In regard to the larynx, ChS accounts for 1% of all laryngeal neoplasms[ 2 , 3 ]. Although these tumours rarely occur in the larynx, they have the second highest frequency after tumours originating from epithelial tissue, squamous cell carcinoma and adenocarcinoma[ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…The increase in the activity of GSα in osteoblast progenitor cells and osteoclasts is stimulated by the amplified production of interleukin-6 stromal cells [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…Monostotic fibrous dysplasia (MFD) is around 10 times more common than polyostotic fibrous dysplasia (PFD) and is frequently unilateral [3,4]. The lack of stable bone matrix formation can manifest in a multitude of ways, involving facial distortion and asymmetry [5][6][7]. In the jaws, tooth movement, occlusion problems, pain, paresthesia, and interference with dental eruption can be observed [3].…”
Section: Introductionmentioning
confidence: 99%
“…The genetic etiology includes activating mutations in the MAP-kinase signaling pathway, KRAS , and FGFR1 mutations. [ 5 ]…”
Section: Introductionmentioning
confidence: 99%